Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Killer Hib virtually wiped out in Africa

12.08.2005


A pioneering vaccination programme for children has virtually wiped out a killer bug in the Gambia – and could save hundreds of thousands of young lives across Africa.

The vaccinations have slashed the incidence of the disease, which causes meningitis and other diseases in babies and infants, to virtually zero.

Paul Milligan of the London School of Hygiene & Tropical Medicine said: “This is an extremely valuable result. It proves that a routine vaccination to eradicate a major killer is achievable and practical.



“And it points the way for other African countries to introduce the same sort of vaccination programme, which has the potential to save a lot of lives and help meet the Millennium Development Goal of cutting the under-five mortality rate in the developing world by two-thirds.”

Since 1997, children in the Gambia have been vaccinated against H. influenzae type b, known as Hib. The bacterium is a major cause of meningitis, which can kill or leave children severely disabled and of potentially fatal pneumonia.

The World Health Organisation (WHO) estimates that Hib kills as many as 700,000 children every year – mostly among children in the developing world aged under five.

Dr Milligan added that, even though there were interruptions to the supply of vaccine in the Gambia programme and less than 70 percent of children got a complete course, the long-term programme, which started in 1997, has still proved highly effective.

He said: “Virtual eradication of the disease has been achieved, even with a less-than-perfect programme, which is particularly relevant to other sub-Saharan African countries.”

Before the introduction of the programme Hib meningitis alone affected 200 per 100,000 babies aged under 12 months and 60 per 100,000 children aged under five.

Only 45 percent of children affected recovered fully from Hib disease and 30 percent of those who contracted meningitis died.

The study was led by the UK Medical Research Council’s Dr Richard Adegbola, and part-funded by WHO.

The research showed that since 2002, Hib transmission has been virtually eliminated – in both vaccinated and unvaccinated children, because the vaccination programme has meant transmission is less likely.

Before the vaccination programme, around 12 percent of children between one and two years old carried the infectious bacteria – that rate is now less than 0.5 percent.

Dr Milligan said: “The study shows the vaccination programme has been an outstanding success – we now need similar programmes across the developing world to reduce the massive rate of death and disability associated with Hib.”

Raymond Hainey | alfa
Further information:
http://www.lshtm.ac.uk

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>